Trastuzumab Resistance: Role for Notch Signaling

Epidermal growth factor receptor-2 (ErbB-2/HER2) is a potent breast oncogene that has been shown to be amplified in 20% of breast cancers. Overexpression of ErbB-2 predicts for aggressive tumor behavior, resistance to some cytotoxic and antihormonal therapies, and poor overall survival. Trastuzumab,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Kinnari, Osipo, Clodia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823123/
https://www.ncbi.nlm.nih.gov/pubmed/20024517
http://dx.doi.org/10.1100/tsw.2009.166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823123/
https://www.ncbi.nlm.nih.gov/pubmed/20024517
http://dx.doi.org/10.1100/tsw.2009.166

Ejemplares similares